Cargando…
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?
Obesity is one of the most important known preventable causes of cancer, accounting for up to 20% of cancer deaths in women. Obese women have increased risk of dying from breast cancer as well as an increased risk of distant metastasis. Metabolic Syndrome (MetSyn) is a group of metabolic conditions...
Autores principales: | Ibarra-Drendall, Catherine, Dietze, Eric C., Seewaldt, Victoria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155025/ https://www.ncbi.nlm.nih.gov/pubmed/21949568 http://dx.doi.org/10.1007/s12609-011-0050-8 |
Ejemplares similares
-
Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer
por: Hoffman, Abigail, et al.
Publicado: (2012) -
Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer
por: Jones, Veronica C., et al.
Publicado: (2020) -
Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin
por: Yee, Lisa D., et al.
Publicado: (2020) -
Vascularity and Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging
por: Frankhouser, David E., et al.
Publicado: (2021) -
Environmental Exposures during Puberty: Window of Breast Cancer Risk and Epigenetic Damage
por: Natarajan, Rama, et al.
Publicado: (2020)